Cohance Lifesciences Limited — Important, 22-10-2024: Updates
22-10-2024 · 11:15 pm
Suven Pharmaceuticals Limited announced approval from the National Company Law Tribunal (NCLT) for the amalgamation of Cohance Lifesciences Limited with itself. The NCLT has ordered meetings of shareholders for both companies to approve the scheme, while dispensing with creditor meetings. Notices will be sent to unsecured creditors and regulatory authorities for their representations regarding the amalgamation.
No comments yet. Be the first to comment!
